Fish Oil Triglycerides Patent Expiration

Fish Oil Triglycerides is Used for treating liver disease and cholestasis in pediatric patients through nutrition therapy. It was first introduced by Fresenius Kabi Usa Llc in its drug Omegaven on Jul 27, 2018.


Fish Oil Triglycerides Patents

Given below is the list of patents protecting Fish Oil Triglycerides, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Omegaven US9566260 Treatment and prevention of liver disease associated with parenteral nutrition (PN) Jul 11, 2025 Fresenius Kabi Usa
Omegaven US9629821 Treatment and prevention of liver disease associated with parenteral nutrition (PN) Jul 11, 2025 Fresenius Kabi Usa
Omegaven US10350186 Treatment and prevention of liver disease associated with parenteral nutrition (PN) Nov 05, 2024 Fresenius Kabi Usa



Fish Oil Triglycerides's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List